...
首页> 外文期刊>Nutrition Research >Bifidobacterium adolescentis IM38 ameliorates high-fat diet-induced colitis in mice by inhibiting NF-kappa B activation and lipopolysaccharide production by gut microbiota
【24h】

Bifidobacterium adolescentis IM38 ameliorates high-fat diet-induced colitis in mice by inhibiting NF-kappa B activation and lipopolysaccharide production by gut microbiota

机译:双歧杆菌IM38通过抑制NF-Kappa B激活和通过肠道微生物产生的脂多糖产生来改善小脂肪饮食诱导的结肠炎。

获取原文
获取原文并翻译 | 示例
           

摘要

Gut microbiota play essential roles in the regulation of human metabolism via symbiotic interactions with the host. Prolonged consumption of high-fat diet (HFD) elevates the Firmicutes to Bacteroidetes ratio and lipopolysaccharide (LPS) production by gut microbiota, thereby increasing the probability of developing metabolic and immune disorders such as obesity and colitis. The use of probiotics with anti-inflammatory properties has been suggested to counteract this effect. Here, we tested whether Bifidobacterium adolescentis IM38, which inhibited nuclear factor-kappa B (NF-kappa B) activation in Caco-2 cells and peritoneal macrophages and inhibited Escherichia coli LPS production, exerted an anticolitic effect in mice with HFD-induced obesity. Oral administration of IM38 (2 x 10(9) CFU/mouse per day) for 6 weeks in mice with HFD-induced obesity inhibited whole-body and epididymal fat weight gain. IM38 also increased HFD-suppressed expression of interleukin (IL)-10 and tight junction proteins but significantly downregulated HFD-induced NF-kappa B activation and tumor necrosis factor expression in the colon. IM38 inhibited differentiation into helper T17 cells and reduced IL17 levels in the colon of mice with HFD-induced obesity but increased HFD-suppressed differentiation into regulatory T cells and IL-10 levels. Furthermore, treatment with IM38 lowered the HFD-induced LPS levels in blood and colonic fluid, as well as the Proteobacteria to Bacteroidetes ratio in gut microbiota. Therefore, we suggest that IM38 can inhibit HFD-induced LPS production in gut microbiota through the regulation of Proteobacteria to Bacteroidetes ratio and NF-kappa B activation in the colon, which ultimately attenuates colitis. Thus, IM38 may be a suitable ingredient of functional foods designed for treating or preventing colitis. (C) 2017 Elsevier Inc. All rights reserved.
机译:Gut Microbiota通过与宿主的共生互动在人体代谢调节中起重要作用。高脂饮食(HFD)的延长消耗升高了肠道微生物的血栓性比和脂多糖(LPS)生产的抵制,从而提高了发育代谢和免疫疾病如肥胖症和结肠炎的可能性。已经提出使用益生菌具有抗炎特性来抵消这种效果。在这里,我们测试了抑制核因子-Kappa B(NF-Kappa B)活化的双歧杆菌ADOLEESTUSIS IM38是否在Caco-2细胞和腹膜巨噬细胞中激活并抑制大肠杆菌LPS产生,施加了HFD诱导的肥胖症的小鼠中的抗侦察作用。 OM38的口服给药6周的IM38(2×10(9)CFU /鼠标),患有HFD诱导的肥胖的小鼠中6周抑制全身和附睾脂肪重量增益。 IM38还增加了白细胞介素(IL)-10和紧密结蛋白的HFD抑制表达,但显着下调的HFD诱导的NF-κB活化和肿瘤坏死因子表达在结肠中。 IM38抑制分化为辅助T17细胞,并在具有HFD诱导的肥胖症的小鼠结肠中降低了IL17水平,但增加了HFD抑制的分化为调节性T细胞和IL-10水平。此外,用IM38治疗降低了血液和结肠液中的HFD诱导的LPS水平,以及肠道微生物肿瘤中的菌丝杆菌的植物菌。因此,我们建议IM38可以通过调节细菌对细菌的血液菌和结肠中的NF-Kappa B活化来抑制肠道微生物的HFD诱导的LPS产生,最终衰减结肠炎。因此,IM38可以是设计用于治疗或预防结肠炎的功能性食品的合适成分。 (c)2017年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号